About us | St. Stamford Modern Cancer Hospital Guangzhou

MCHG
Hospital Qualification
Development History
Hospital Honors
Medical Technology
MDT Team
Services and Facilities
Hospital Environment

St. Stamford Modern Cancer Hospital Guangzhou (MCHG)

    Established in 2005, St. Stamford Modern Cancer Hospital Guangzhou is a joint venture of Singapore Perennial Real Estate Holdings Limited and China Boai Medical Group, a Chinese oncology hospital specializing in cancer treatment, with international advanced minimally invasive cancer treatment technology, professional MDT medical team and caring medical services. In 2014, St. Stamford Modern Cancer Hospital Guangzhou has been successfully accredited by JCI (Joint Commission International), which assesses and evaluates with strict standards in the world and stands for the highest level of medical service and hospital management.
     Adhering to the construction principle of “high starting point, high standard and high taste”, the hospital has introduced more than 100 sets of large-scale equipments such as American large-scale flat-panel digital subtraction angiography, GE 128-slice spiral CT, digital mammography system, Toshiba DR, Japanese fully automated analyser, German Color Doppler, laparoscopy and hysteroscopy, German Dräger argon-helicium knife, nano-knife, Olympus Fibre Bronchoscope, Morestep endogenous field thermal therapy system, German ureteroscopy and nephroscopy, etc.
   Based on China and facing the world, our hospital has formed international cooperation relationships with more than 20 overseas medical institutions and research institutes and friendship cooperation hospitals with many international hospitals in the world, with branches all over the world, including Vietnam, Indonesia, the Philippines, Bangladesh, Cambodia, Thailand and Malaysia.

18
with 18 years of international cancer patient service experience
10
with 10 international branches for service extension
100+
with 100+ pieces of large medical equipments
180000
With a total construction area of 180000㎡

Hospital Qualification

Member of the Joint Committee for the Accreditation of International Medical and Health Institutions
Member of the International Union Against Cancer
Partner of Malaysia Penang Anti-Cancer Association
Member of China Anti-Cancer Association
A formal hospital approved by the Ministry of Health of China

Development History

2005

On August 28, Singapore St. Stamford International Medical was formally established
Designated Hospital for Members of Europe-China Joint Chamber of Commerce
2006

Overseas strategy officially launched
Indonesian Chinese Hospital, Naval Hospital Cooperation Organization
The office in Jakarta, Indonesia was established
2007

Cooperation unit of Guangdong Provincial People's Hospital
Member unit of China Anti-Cancer Association
2008

The only hospital designated by the Chinese Ministry of Health
Invited by the South African Presidential Office to visit South Africa
Officially established offices in Ho Chi Minh and Hanoi, Vietnam
2009

Guangzhou Medical Insurance Designated Institution
Establishment of medical office in Thailand
Invited by the China-Africa Chamber of Commerce to visit the medical industry in the United Arab Emirates, Saudi Arabia and Egypt
2010

Co-organized the 21st World Anti-Cancer Congress
The mayor of Manila, Philippines cordially received the delegation of Modern Hospital
2011

Hosted the 7th China Minimally Invasive Tumor Conference and Southeast Asia Tumor Forum
Boai Modern Charity Foundation officially launched
The office in Manila, Philippines was established
2012

Southern Medical University Health Law Practice Base
The Cambodia office was established
The office in Dhaka, Bangladesh was established
2013

Top 30 Sustainable Development Capabilities in Guangdong Province
Golam Moshi, an official from the Bangladeshi Presidential Palace, and his delegation visited
2014

In October 2014, the hospital was accredited with JCI for the first time
Vice President Unit of Guangdong Sub-Health Service Association
2015

Education base of Guangdong College of Pharmacy
Sino-Singapore joint venture medical institution
National University Hospital of Singapore strategic partner
2016

Interview with Mayo Clinic
China's first Singapore joint venture JCI District Institute launched a press conference
Professor Zhang Fujun became the Chief Scientist of the Department of Minimally Invasive Tumor in our hospital
Most Valuable Industry Award
2017

The Municipal Health and Family Planning Bureau allocated special funds for scientific research projects in our institute
Fan Daiming, an academician of the Chinese Academy of Engineering, wrote an inscription for our institute
Passed JCI review
2018

博爱-Bhai-Foxconn Smart Medical Demonstration Exchange Meeting
An organization member of Chinese Anti-Cancer Association
2019

CINV standardized treatment ward started
Member unit of Southern Tumor Minimally Invasive Intervention Alliance
Won two third prizes in the second national QC competition
2020

Precision Medicine Science Center of Sun Yat-sun University jointly builds a tumor center
2021

Modern Hospital Guangzhou was one of the first medical institutes in the mainland of China qualified to obtain medicine and medical instruments from Hong Kong and Macao
2023

Modern Hospital Guangzhou was approved to establish the Chinese Anti-Cancer Association (CACA) to set up the Belt and Road Integrated Oncology Medical Training Base (Guangdong)

Hospital Honors

Treatment Technologies

Interventional Therapy

Mainly used in liver cancer, lung cancer, breast cancer, colorectal cancer, cervical cancer, nasopharyngeal cancer, thyroid cancer, prostate cancer, gastric cancer and other solid tumors.

Interventional therapy is a mini-invasive therapy performed under the guidance of medical imaging equipments. With a 1-2 millimeter incision, paracentesis can be performed with the lead of medical imaging equipment....

/treatment-technologies/2023/0728/7020.html

Cryotherapy

Liver cancer, lung cancer, breast cancer, colon cancer, cervical cancer, nasopharyngeal cancer, thyroid cancer, prostate cancer, stomach cancer and other solid tumor

Cryotherapy, also named cryosurgery therapy or cryoablation, is a medical technique both ancient and modern....

/treatment-technologies/2023/0728/7021.html

Combined Knife

Liver cancer, lung cancer, pancreatic cancer, thyroid cancer, prostate cancer, kidney cancer, adrenal tumor and primary and metastatic solid tumors in various organs such as abdominal and pelvic tumor

Combined Knife, it’s not actual surgical knife, but a composite cryogenic freezing surgical system, which conduct cold and heat ablation treatment with liquid-nitrogen by one or more ablation needles, it’s called combined knife because of its accuracy. ...

/treatment-technologies/2023/0818/7311.html

Particle Knife

Lung cancer, prostate cancer, breast cancer, liver cancer, nasopharyngeal cancer, tongue cancer, carcinoma of parotid gland, carcinoma of tonsil, cervical cancer, endometrial cancer, etc.

Particle knife (also called 125I Seed Implants) is applied to a variety of primary and metastatic tumors nowadays. 125I seeds are some small iodine radioactive particles that can give off short-range γ-ray to kill tumor cells continuously. 125I seed implantation can achieve the same internal radiati...

/treatment-technologies/2023/0818/7349.html

DEB-TACE

Solid tumors such as Liver Cancer, lung cancer, breast cancer, colon cancer, cervical cancer, nasopharyngeal cancer, thyroid cancer, prostate cancer, stomach cancer, etc.

Drug-eluting beads transcatheter arterial chemoembolization (DEB-TACE) is an interventional therapy used in tumor treatment. It is a tiny sphere made of polymers or ceramics with a certain range of sizes and with anti-tumor drugs encapsulated inside. Its main function is to embolize the vessels suppl...

/treatment-technologies/2023/0818/7346.html

Nanoknife Technology

Pancreatic cancer, liver cancer, lung cancer, kidney cancer, prostate cancer and other solid tumors, especially for tumors near the hilar area, gallbladder, bile duct, pancreas, and ureter

Nanoknife is a brand-new cutting-edge ablation technology for tumor treatment. It breaks the membrane of tumor cells with high voltage pulses from electrode probes, resulting in multiple irreversible nano-meter electroporated holes, which is applicable to pancreatic cancer, liver cancer and other sol...

/treatment-technologies/2023/0818/7327.html

Radiofrequency Ablation

Liver cancer, lung cancer, breast cancer and other metastatic tumor

Radiofrequency ablation, sometimes referred to as RFA, is a minimally invasive treatment for cancer. It is an image-guided technique that heats and destroys cancer cells.　Under the guidance of image, RFA, a physical method to inactive and kill the tumor, is performed with minimally invasive paracen...

MDT Team

: Song Shijun; Chief Expert of Oncology Department | Chief physician

: Liu Yuansheng; Minimally Invasive Dean, Integrative Medicine Chief Expert | Deputy Chief Physician

: Peng Xiaochi; Director of International Oncology Ward | Chief Physician

: Dai Wenyan; Director of Ward 8, Department of Oncology, Director of Breast Cancer Center | Associate Chief Physician

: Ma Xiaoying; Director of Oncology Department | Associate Chief Physician

: Lin Jing; Deputy Director, International Oncology Ward | Attending Physician

Services and Facilities

St. Stamford Modern Cancer Hospital Guangzhou has a total construction area of 180,000 square meters, 180 approved beds, 293 beds, and more than 400 employees.
With a comfortable and warm environment and advanced medical equipment technology, it provides high-quality medical services for patients from all over the world.
St. Stamford Modern Cancer Hospital Guangzhou has been adhering to the service tenet of "everything is patient-centered", providing each patient with humanized, comprehensive and high-quality medical services.